Question 1

What is Abbott Laboratories's P/E ratio?

Accepted Answer

Abbott Laboratories (ABT) P/E ratio is 25.4× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month earnings (net income), using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/E ratio calculated?

Accepted Answer

P/E = Share Price ÷ Trailing Twelve-Month (TTM) Diluted EPS, or equivalently Market Capitalisation ÷ TTM Net Income. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/E ratio?

Accepted Answer

The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.

Question 4

What is a good P/E ratio for Abbott Laboratories?

Accepted Answer

There is no universal "good" P/E. As a rule of thumb, the S&P 500 has historically averaged a P/E in the mid-to-high teens; mature, slow-growth businesses commonly trade in the 10–18× range, while high-growth or asset-light companies often trade at 25–50×+. What matters is the comparison to sector peers and to the company's own historical range. For Abbott Laboratories specifically, the relevant sector benchmark is the current sector median of 25.0×.

Question 5

Is Abbott Laboratories's P/E ratio high or low?

Accepted Answer

Abbott Laboratories's P/E ratio of 25.4× is below its own 5-year average of 27.8× and above the sector median of 25.0×. That places the current reading at the 38th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Abbott Laboratories's historical P/E ratio range?

Accepted Answer

In the available daily series, Abbott Laboratories (ABT) P/E ratio has ranged from a low of 6.4× in 2009 to a high of 220.7× in 2018. The 5-year average is 27.8× and the 5-year median is 29.6×.

Question 7

What was Abbott Laboratories's P/E ratio in 2025?

Accepted Answer

Abbott Laboratories (ABT) P/E ratio at the end of 2025 was 33.6×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month earnings figure available at that date.

Question 8

Why does Abbott Laboratories's P/E ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (earnings). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$218.88B	$6.52B	33.6×	+18.9×	Dec 31, 2025
2024	$195.87B	$13.40B	14.6×	-18.7×	Dec 31, 2024
2023	$190.87B	$5.72B	33.4×	+5.8×	Dec 31, 2023
2022	$190.79B	$6.93B	27.5×	-7.6×	Dec 31, 2022
2021	$248.28B	$7.07B	35.1×	-8.0×	Dec 31, 2021
2020	$193.93B	$4.50B	43.1×	+1.6×	Dec 31, 2020
2019	$153.09B	$3.69B	41.5×	-12.1×	Dec 31, 2019
2018	$126.98B	$2.37B	53.6×	-155.0×	Dec 31, 2018
2017	$99.51B	$477.00M	208.6×	+168.2×	Dec 31, 2017
2016	$56.57B	$1.40B	40.4×	+25.5×	Dec 31, 2016
2015	$66.14B	$4.42B	15.0×	-14.8×	Dec 31, 2015
2014	$67.89B	$2.28B	29.7×	+6.7×	Dec 31, 2014
2013	$59.34B	$2.58B	23.0×	+14.8×	Dec 31, 2013
2012	$48.85B	$5.96B	8.2×	-0.8×	Dec 31, 2012
2011	$42.32B	$4.73B	9.0×	+1.3×	Dec 31, 2011
2010	$35.62B	$4.63B	7.7×	+0.8×	Dec 31, 2010
2009	$39.87B	$5.75B	6.9×	-1.1×	Dec 31, 2009
2008	$39.46B	$4.88B	8.1×	-3.4×	Dec 31, 2008
2007	$41.47B	$3.61B	11.5×	-9.4×	Dec 31, 2007
2006	$35.89B	$1.72B	20.9×	+12.3×	Dec 31, 2006
2005	$28.85B	$3.37B	8.6×	-2.2×	Dec 31, 2005
2004	$34.74B	$3.24B	10.7×	-1.2×	Dec 31, 2004
2003	$32.73B	$2.75B	11.9×	+1.8×	Dec 31, 2003
2002	$28.09B	$2.79B	10.1×	-15.1×	Dec 31, 2002
2001	$39.05B	$1.55B	25.2×	—	Dec 31, 2001


Medtronic (MDT)	22.2×
McKesson (MCK)	22.2×
Illumina (ILMN)	21.7×
ResMed (RMD)	21.6×
GE HealthCare (GEHC)	21.6×
Pfizer (PFE)	21.1×
Quest Diagnostics (DGX)	21.1×
Henry Schein (HSIC)	21.0×
AptarGroup (ATR)	20.9×
IQVIA (IQV)	20.7×
UnitedHealth Group (UNH)	20.4×
Biogen (BIIB)	19.7×
Zoetis (ZTS)	18.9×
Gilead Sciences (GILD)	18.8×
Humana (HUM)	18.5×
Regeneron Pharmaceuticals (REGN)	18.2×
Bristol-Myers Squibb (BMY)	17.0×
HCA Healthcare (HCA)	15.8×
DaVita (DVA)	13.3×
Incyte (INCY)	13.1×
Elevance Health (ELV)	12.3×
Cigna (CI)	11.1×
Novo Nordisk (NVO)	8.6×
Solventum (SOLV)	7.9×
Universal Health Services (UHS)	7.2×

P/E Ratio for Abbott Laboratories (ABT)

P/E Ratio daily chart for Abbott Laboratories (ABT)

Historical P/E Ratio for Abbott Laboratories (ABT) from 2001 to 2025

About P/E Ratio at Abbott Laboratories (ABT)

Abbott Laboratories P/E Ratio by Year

Abbott Laboratories P/E Ratio 2025: 33.6×

Abbott Laboratories P/E Ratio 2024: 14.6×

Abbott Laboratories P/E Ratio 2023: 33.4×

Abbott Laboratories P/E Ratio 2022: 27.5×

Abbott Laboratories P/E Ratio 2021: 35.1×

Sector peers by P/E Ratio — chart

Sector peers by P/E Ratio — table

Frequently asked questions

Abbott Laboratories (ABT) Key Financials

P/E Ratio daily chart for Abbott Laboratories (ABT)

Historical P/E Ratio for Abbott Laboratories (ABT) from 2001 to 2025

About P/E Ratio at Abbott Laboratories (ABT)

Abbott Laboratories P/E Ratio by Year

Abbott Laboratories P/E Ratio 2025: 33.6×

Abbott Laboratories P/E Ratio 2024: 14.6×

Abbott Laboratories P/E Ratio 2023: 33.4×

Abbott Laboratories P/E Ratio 2022: 27.5×

Abbott Laboratories P/E Ratio 2021: 35.1×

Sector peers by P/E Ratio — chart

Sector peers by P/E Ratio — table

Frequently asked questions

+What is Abbott Laboratories's P/E ratio?

+How is the P/E ratio calculated?

+What is the P/E ratio?

+What is a good P/E ratio for Abbott Laboratories?

+Is Abbott Laboratories's P/E ratio high or low?

+What is Abbott Laboratories's historical P/E ratio range?

+What was Abbott Laboratories's P/E ratio in 2025?

+Why does Abbott Laboratories's P/E ratio change over time?

Abbott Laboratories (ABT) Key Financials